1222.5.20 Boehringer Ingelheim Investigational Site

Tacoma, Washington

0 studies enrolling now · 1 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. — Completed